Clinical Trial Update: ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

View source ↗

Summary

A multi-institution retrospective study evaluating digital pathology outcome prediction in ALK-positive non-small cell lung cancer treated with ALK inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alk-positive Non-small Cell Lung Cancer

Snippet

Sponsor: Sheba Medical Center | Conditions: Alk-positive Non-Small Cell Lung Cancer, ALK-inhibitor Treated | Status: ENROLLING_BY_INVITATION